Tenderwize
Zurück zur Suche

Open House Biologics Discount Agreement for Follitropin delta

Techniker Krankenkasse·Hamburg, Germany·Deadline Aug 30, 2026 · 30 days left·Open·Supplies
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2025-07 - Follitropin delta

62/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Warum diese Bewertung?

Chance

62 / 100

Komplexität

58 / 100

Risikofaktoren

The structured data states a maximum contract term ending 31.05.2027, while the XML notice says the procedure ends earl...

Electronic submission via the portal is not allowed; the XML notice requires email with qualified electronic signature...

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • Supplies contract
  • 1 lot
  • Duration until Jun 2026
  • Open House discount agreements for pharmaceutical products, specifically Follitropin delta.
  • Nationwide performance in Germany.
Vollständige Zusammenfassung anzeigen

Open House supply arrangement by Techniker Krankenkasse for the active substance Follitropin delta (CPV 33600000). The procedure is non-exclusive, with no individual negotiations and uniform terms. Participation is open throughout the contract period, but the notice states the procedure will end early on 30.08.2026 and a follow-on procedure will be launched. Procurement documents are available online, but no separate procurement document text was provided for analysis beyond the XML notice extract.

Risiken

The structured data states a maximum contract term ending 31.05.2027, while the XML notice says the procedure ends earl...

Electronic submission via the portal is not allowed; the XML notice requires email with qualified electronic signature...

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Applicant must be a pharmaceutical undertaking within the meaning of § 4(18) AMG for the relevant medicinal product.
  • Applicant must have its seat in the AMG territory, another EU Member State, or another EEA state.
  • Applicant must hold a valid marketing authorisation for the relevant medicinal product or otherwise be entitled to place it on the market in its own name.

Auftraggeber

Ort

Hamburg, DEU

Kennung

992-80116-93

Tätigkeit

Health

Lose (1)

LOT-0001

Open House Biologics Discount Agreement for Follitropin delta

Supply lot for discount agreements under § 130a(8) SGB V concerning Follitropin delta. The lot is nationwide in Germany and follows Open House terms with no exclusivity and no individual negotiation. The XML notice indicates the procedure will end early on 30.08.2026, although the structured data also states a maximum contract term ending 31.05.2027; this inconsistency affects timing and should be clarified.

SuppliesEU fundedElectronic submission

Ort

DE600, Germany

Dauer

May 2025 - Jun 2026

Kategorie

Pharmaceutical products

Frist

Deadline Aug 30, 2026

Vergabedetails

Veröffentlichungsdatum
08 Jul 2026
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
474600-2026

Dokumente (1)

Ähnliche Ausschreibungen